K2M Expands 3D-Printed MIS Cascadia Lateral Interbody System

K2M Group Holdings Inc., a designer, developer, and commercializer of proprietary complex spine and minimally invasive spine technologies and techniques, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand its Cascadia Lateral Interbody System featuring Lamellar 3D titanium technology, which uses 3D printing to allow for bony integration throughout an implant. The Cascadia Lateral Interbody System line extension clearance strengthens K2M’s minimally invasive surgery (MIS) portfolio and the company’s market position in the 3D printing of spinal devices.
 
“Cascadia is an exciting innovation for lateral spine fusions,” said Greg T. Poulter, M.D., an orthopedic spine surgeon at OrthoIndy. “The unique engineering and 3D printing allows the implant to have the biocompatibility and ongrowth characteristics of titanium, while allowing a stiffness that more closely matches bone. The graft volume and surface area for fusion are generous and the new size options for lordosis allow me to address each patient’s individual sagittal plane requirements. Cascadia has become my go-to implant for lateral interbody fusions.”
 
K2M’s Lamellar 3D titanium technology uses an advanced 3D printing method to create structures that are impossible with traditional manufacturing techniques. Starting with a titanium powder, the Cascadia implants are grown through the selective application of a high-energy laser beam, incorporating complex internal geometries and rough surface architecture that pre-clinical data have associated with bone growth activity.
 
Lamellar 3D titanium technology incorporates a porous structure along with rough surfaces to allow the potential for bony integration throughout the implant. K2M’s Cascadia interbodies utilize this technology to create a 70 percent porous implant with an increased bone graft volume and similar stiffness when compared to K2M PEEK (polyether ether ketone) designs.

Learn more about the Cascadia System by watching the video below:

 

The Cascadia Lateral Interbody System is part of the company’s minimally invasive surgical (MIS) portfolio, designed to promote less invasive access to the spine. The system functions as an invertebral body fusion device to provide support and stabilization of the lumbar segments of the spine. Its reverse hourglass implant design promotes increased endplate contact—compared to an Aleutian PEEK implant—without sacrificing internal bone graft volume. The system includes a full range of implant sizes and heights that are carefully designed to accommodate vertebral anatomy, and it is intended to work in conjunction with the Ravine Lateral Access System to offer a full line of instrumentation for the far lateral transpsoas approach.
                                                                                                                                                    
“K2M is proud to strengthen our portfolio of FDA-cleared, 3D-printed spinal solutions, thus reinforcing our competitive advantage in this space,” said K2M President and CEO Eric Major. “MIS procedures and 3D printing are core competencies for K2M, as indicated by the breadth and depth of our product offerings. We continue to be committed to innovating the highest quality products to create improved treatments for patients who suffer from debilitating complex spinal deformities.”
 
The complete Cascadia portfolio also includes the Cascadia TL, AN, AN Lordotic Oblique, and Cervical Interbody Systems.
 
K2M Group Holdings is headquartered in Leesburg, Va.